References
- SulkMSeeligerSAubertJDistribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosaceaJ Invest Dermatol201213241253126222189789
- KajiyaKKajiya-SawaneMOnoTSatoKIdentification of an epidermal marker for reddened skin: vascular endothelial growth factor AJ Dermatol201744783683728677138
- YamasakiKGalloRLRosacea as a disease of cathelicidins and skin innate immunityJ Investig Dermatol Symp Proc20111511215
- ReinholzMRuzickaTSchauberJCathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin diseaseAnn Dermatol201224212613522577261
- JangYHSimJHKangHYKimYCLeeESImmunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosaceaJ Eur Acad Dermatol Venereol201125554454820698913
- KähäriVMSaarialho-KereUMatrix metalloproteinases in skinExp Dermatol1997651992139450622
- KangSChoSChungJHHammerbergCFisherGJVoorheesJJInflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivoAm J Pathol200516661691169915920154
- KanadaKNNakatsujiTGalloRLDoxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidinJ Invest Dermatol201213251435144222336948
- BoisnicSBranchet-GumilaMCBenslamaLLe CharpentierYArnaud-BattandierJLong term culture of normal skin to test the efficacy of a hydroxy acid-containing creamEur J Dermatol199774271273
- SteinhoffMSchauberJLeydenJJNew insights into rosacea pathophysiology: a review of recent findingsJ Am Acad Dermatol2013696 Suppl 1S15S2624229632
- BergMLidénSAn epidemiological study of rosaceaActa Derm Venereol19896954194232572109
- AbramKSilmHOonaMPrevalence of rosacea in an Estonian working population using a standard classificationActa Derm Venereol201090326927320526544
- ChosidowOCribierBEpidemiology of rosacea: updated dataAnn Dermatol Venereol2011138Suppl 3S179S18322183096
- SpoendlinJVoegelJJJickSSMeierCRA study on the epidemiology of rosacea in the U.KBr J Dermatol2012167359860522564022
- RainerBMKangSChienALRosacea: epidemiology, pathogenesis, and treatmentDermatoendocrinology201791e1361574
- GuexJJAvrilLEnriciEEnriquezELisCTaïebCQuality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study)Int Angiol201029652553221173734
- JawienABouskelaEAllaertFANicolaïdesANThe place of Ruscus extract, hesperidin methyl chalcone, and vitamin C in the management of chronic venous diseaseInt Angiol2017361314128124877
- Pinho-RibeiroFAHohmannMSBorghiSMProtective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice: role of TRPV1, oxidative stress, cytokines and NF-κBChem Biol Interact2015228889925617481
- MartinezRMPinho-RibeiroFASteffenVSHesperidin methyl chalcone inhibits oxidative stress and inflammation in a mouse model of ultraviolet B irradiation-induced skin damageJ Photochem Photobiol B201514814515325916506
- MartinezRMPinho-RibeiroFASteffenVSTopical formulation containing hesperidin methyl chalcone inhibits skin oxidative stress and inflammation induced by ultraviolet B irradiationPhotochem Photobiol Sci201615455456327021784
- RiveroALWhitfeldMAn update on the treatment of rosaceaAust Prescr2018411202429507456
- van ZuurenEJFedorowiczZCarterBvan der LindenMMCharlandLInterventions for rosaceaCochrane Database Syst Rev20154CD003262